Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004907850 | SCV005570756 | uncertain significance | not specified | 2024-08-07 | criteria provided, single submitter | clinical testing | The c.40G>A (p.G14R) alteration is located in exon 2 (coding exon 2) of the CYTH4 gene. This alteration results from a G to A substitution at nucleotide position 40, causing the glycine (G) at amino acid position 14 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Department of Clinical Pathology, |
RCV004560221 | SCV004217879 | likely benign | EBV-positive nodal T- and NK-cell lymphoma | no assertion criteria provided | research |